Solara Active PP

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IN9624Z01022
  • NSEID: SOLARAPP1
  • BSEID: 890202
INR
308.70
0.00 (0.00%)
BSENSE

Sep 02, 03:30 PM

BSE+NSE Vol: 3.45 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Why is Solara Active Pharma Sciences Ltd Partly Paidup falling/rising?

02-Sep-2026

As of 01-Sep, the stock price of Solara Active Pharma Sciences Ltd Partly Paidup is stable at Rs 308.70, showing no change (0.00%). Despite a short-term gain of 12.87%, the stock has declined 29.71% over the past year, indicating a concerning long-term outlook amid decreasing investor engagement.

As of 01-Sep, the stock price of Solara Active Pharma Sciences Ltd Partly Paidup is stable at Rs 308.70, showing no change (0.00%). Despite this stability, the stock has experienced a significant decline over the past year, with a decrease of 29.71%, while the benchmark Sensex has only fallen by 4.26% during the same period. <BR><BR>Today, the stock opened with a notable gain of 12.87%, reaching an intraday high of Rs 308.70, which indicates a positive movement at the start of the trading session. Additionally, it outperformed its sector by 13.15%. However, the stock has shown erratic trading patterns, having not traded on one day out of the last 20 days, and there has been a decline in investor participation, with delivery volume falling by 14.1% compared to the 5-day average.<BR><BR>The stock's performance against moving averages indicates that it is currently higher than the 5-day and 20-day moving averages but lower than the 50-day, 100-day, and 200-day moving averages, suggesting mixed signals regarding its longer-term trend. Overall, while there are short-term gains today, the longer-term outlook remains concerning due to the substantial decline over the past year and decreasing investor engagement.

View full answer

Which are the latest news on Solara Active PP?

02-Sep-2026
No latest news for Solara Active PP found.

What does Solara Active PP do?

01-Sep-2026

Solara Active Pharma Sciences Ltd Partly Paidup is a Micro Cap company in the Pharmaceuticals & Biotechnology industry, with no reported sales or profits for the latest quarter and a market cap of INR 370 Cr. Key financial metrics such as P/E, dividend yield, and return on equity are all reported as 0.00%.

Overview:<BR>Solara Active Pharma Sciences Ltd Partly Paidup operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>The incorporation year and any status changes are not provided, and there are no reported sales or profit figures for the latest quarter.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 370 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A<BR>Industry P/E: N/A<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 0.00<BR>Return on Equity: 0.00%<BR>Price-to-Book: 0.00<BR><BR>Contact Details:<BR>Registrar Address: Not available.

View full answer

Who are the peers of the Solara Active PP?

01-Sep-2026

Peers of Solara Active PP include Bacil Pharma, Zenith Health, Desh Rakshak, Dipna Pharmachem, and others. Unjha Formul. leads with a 1-year return of 10.70%, while Dipna Pharmachem has the lowest at -73.42%.

Peers: The peers of Solara Active PP are Bacil Pharma, Zenith Health, Desh Rakshak, Dipna Pharmachem, Starsource Multi, Ortin Global, Unjha Formul., Beryl Drugs, and Mono Pharmacare.<BR><BR>Quality Snapshot: Excellent growth is observed at Dipna Pharmachem, while Below Average management risk is found at Zenith Health, Desh Rakshak, Dipna Pharmachem, Ortin Global, Beryl Drugs, and Mono Pharmacare, and the rest. Average management risk is found at Unjha Formul., while Bacil Pharma and Starsource Multi do not qualify in management risk, growth, and capital structure. Good capital structure is noted at Zenith Health and Unjha Formul., while Below Average capital structure is seen at Desh Rakshak, Dipna Pharmachem, Ortin Global, Beryl Drugs, and Mono Pharmacare, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Unjha Formul. at 10.70%, while the lowest is Dipna Pharmachem at -73.42%. Solara Active PP's 1-year return of -29.54% is better than Dipna Pharmachem's but worse than Unjha Formul.'s. Additionally, Bacil Pharma, Desh Rakshak, Dipna Pharmachem, and Mono Pharmacare have negative six-month returns.

View full answer

How big is Solara Active PP?

01-Sep-2026

As of 31st August, Solara Active Pharma Sciences Ltd Partly Paidup has a market capitalization of 370.00 Cr, categorized as a Micro Cap, with no valid financial data available for recent quarters or annual balance sheet metrics.

As of 31st August, <BR><BR>Market Cap: Solara Active Pharma Sciences Ltd Partly Paidup has a market capitalization of 370.00 Cr, categorized as a Micro Cap.<BR><BR>Recent Quarterly Performance: No valid financial data is available for the latest quarters, including Net Sales and Net Profit.<BR><BR>Balance Sheet Snapshot: There is no valid annual balance sheet data available, including values for Shareholder's Funds and Total Assets.

View full answer

What is the technical trend for Solara Active PP?

09-Jun-2025

As of June 4, 2025, Solara Active PP shows a neutral trend with a slight bullish inclination due to a mildly bullish weekly MACD and RSI, despite daily moving averages being mildly bearish and no clear trend from Dow Theory and OBV.

As of 4 June 2025, the technical trend for Solara Active PP has changed from mildly bearish to sideways. The weekly MACD is mildly bullish, and the RSI is bullish, indicating some positive momentum in the short term. However, daily moving averages are mildly bearish, suggesting caution. The Bollinger Bands on the weekly chart are also bullish, supporting the upward potential. Dow Theory and OBV show no clear trend in both weekly and monthly time frames, indicating a lack of strong directional movement. Overall, the current stance is neutral with a slight bullish inclination, driven primarily by the weekly MACD and RSI.

View full answer

How has been the historical performance of the Solara Active PP?

07-Jun-2025

No Data Available for this Stock

When is the next results date for Solara Active PP?

06-Jun-2025

No Upcoming Board Meetings

Has Solara Active PP declared dividend?

06-Jun-2025

No Dividend History Available

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 370 Cr (Micro Cap)

stock-summary
P/E

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
2.47%
0%
2.47%
1 Year
0%
0%
0.0%
2 Years
-18.26%
0%
-18.26%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Solara Active PP for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Intimation In Connection With The Receipt Of Rectification Order

28-Aug-2026 | Source : BSE

Solara Active Pharma Sciences Limited has informed the exchange about intimation in connection with the receipt of Rectification Order

Announcement under Regulation 30 (LODR)-Newspaper Publication

26-Aug-2026 | Source : BSE

Newspaper publication regarding the completion of dispatch of 9th AGM Notice and Annual report

Reg. 34 (1) Annual Report.

25-Aug-2026 | Source : BSE

Annual Report for the financial year ended March 31 2026

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
Industry P/E
0
Price to Book Value
EV to EBIT
EV to EBITDA
EV to Capital Employed
EV to Sales
PEG Ratio
NA
Dividend Yield
ROCE (Latest)
ROE (Latest)

Technicals key factors

Indicator
Weekly
Monthly
Icon
Technical indicator has not been calculated since the stock has been active for a short period
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Solara Active PP"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Solara Active PP"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Solara Active PP"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Solara Active PP"
  }
]
stock-summaryCompany CV
About Solara Active Pharma Sciences Ltd Partly Paidup stock-summary
stock-summary
Solara Active Pharma Sciences Ltd Partly Paidup
Micro Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available